Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 3, Pages e58961
Publisher
Public Library of Science (PLoS)
Online
2013-03-22
DOI
10.1371/journal.pone.0058961
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Serum Leptin, Parathyroid Hormone, 1,25-Dihydroxyvitamin D, Fibroblast Growth Factor 23, Bone Alkaline Phosphatase, and Sclerostin Relationships in Obesity
- (2012) Elizabeth Grethen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results
- (2011) Malgorzata Wojcik et al. CLINICAL ENDOCRINOLOGY
- Fibroblast Growth Factor 23, Cardiovascular Disease Risk Factors, and Phosphorus Intake in the Health Professionals Follow-up Study
- (2011) O. M. Gutierrez et al. Clinical Journal of the American Society of Nephrology
- Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans
- (2011) Erik A. Imel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
- (2011) E. G. Farrow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acute hyperinsulinemia is followed by increased serum concentrations of fibroblast growth factor 23 in type 2 diabetes patients
- (2011) Kristian Winther et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- The Serum Level of Fibroblast Growth Factor-23 and Calcium-Phosphate Homeostasis in Obese Perimenopausal Women
- (2011) M. Holecki et al. International Journal of Endocrinology
- Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals
- (2010) Majd A.I. Mirza et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1α,25-dihydroxyvitamin D3 synthesis in leptin-deficient ob/ob Mice
- (2010) Kiyomi Tsuji et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Circulating Pigment Epithelium-Derived Factor Levels Are Associated with Insulin Resistance and Decrease after Weight Loss
- (2010) Mònica Sabater et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
- (2009) Heng Jung Hsu et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Relationship between circulating FGF23 and total body atherosclerosis in the community
- (2009) Majd A. I. Mirza et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
- (2009) G. Jean et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
- (2009) R. Goetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bone as an endocrine organ
- (2009) Seiji Fukumoto et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men
- (2008) R. Marsell et al. OSTEOPOROSIS INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started